Quantitative Systematic Strategies’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-16,299
Closed -$340K 200
2021
Q2
$340K Sell
16,299
-11,322
-41% -$281K 0.12% 311
2021
Q1
$781K Buy
27,621
+1,678
+6% +$53.1K 0.12% 278
2020
Q4
$847K Buy
25,943
+15,204
+142% +$534K 0.12% 278
2020
Q3
$329K Buy
+10,739
New +$237K 0.06% 413
2018
Q4
Sell
-13,414
Closed -$235K 782
2018
Q3
$235K Buy
+13,414
New +$257K 0.04% 478

Other funds holding KURA

Quantitative Systematic Strategies's KURA Position: Q3 2021 in Review

Quantitative Systematic Strategies sold out of Kura Oncology (KURA) in Q3 2021, closing a stake of 16,299 shares — an estimated $340K sold.

Quantitative Systematic Strategies first reported a position in KURA in Q3 2018 and held it in 5 quarters. The position peaked at $847K in Q4 2020. 152 funds tracked by Wall St. Rank hold KURA as of Q3 2021.

  • Quantitative Systematic Strategies reported no remaining Kura Oncology position as of Q3 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 16,299 Kura Oncology shares in Q3 2021, an estimated $340K.
  • Quantitative Systematic Strategies first reported a position in Kura Oncology in Q3 2018 and held it in 5 quarters.
  • Quantitative Systematic Strategies's Kura Oncology position peaked at $847K in Q4 2020.
  • 152 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2021, filed 16 Nov 2021.